---
title: "Zhejiang Hisun Biomaterials Co.Ltd. (688203.SH)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/688203.SH.md"
symbol: "688203.SH"
name: "Zhejiang Hisun Biomaterials Co.Ltd."
industry: "Commodity Chemicals"
---

# Zhejiang Hisun Biomaterials Co.Ltd. (688203.SH)

| Item | Detail |
|------|--------|
| Industry | Commodity Chemicals |
| Location | CN Market |
| Website | [www.hisunplas.com](https://www.hisunplas.com) |

## Company Profile

Zhejiang Hisun Biomaterials Co.Ltd. engages in the research, development, production, and sale of polylactic acid in China. The company's products are used in various applications that include 3D printing, extrusion, thermoforming, film blowing and laminating, injection molding, meltblown non-woven ...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-17T04:30:08.000Z

**Overall: C (0.52)**

**Industry**: Commodity Chemicals

| Metric | Value |
|--------|-------|
| Industry Ranking | 210 / 271 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -6.40% |  |
| Net Profit YoY | -82.48% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 1.84 |  |
| Dividend Ratio | 0.45% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 2.71B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 807.37M |  |


**Multi Score**: C

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 0.47% | D |
| Profit Margin | 0.86% | C |
| Gross Margin | 12.07% | D |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -6.40% | D |
| Net Profit YoY | -82.48% | E |
| Total Assets YoY | 1.77% | C |
| Net Assets YoY | -1.63% | D |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 11605.33% | A |
| OCF YoY | -6.40% | D |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.40 | C |

#### Debt Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 28.44% | B |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Zhejiang Hisun Biomaterials Co.Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "0.47%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "0.86%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "12.07%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-6.40%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-82.48%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "1.77%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "-1.63%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "11605.33%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "-6.40%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.40",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "B",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "28.44%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | ZJJH (SH.600160) | B | A | B | B | B | B |
| 02 | TINCI (SZ.002709) | C | B | B | C | A | B |
| 03 | SINOMATECH (SZ.002080) | C | B | C | D | B | B |
| 04 | STL (SZ.002648) | B | B | B | C | B | B |
| 05 | Grace (SH.603256) | B | A | C | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 389.24 | 185/280 | 379.33 | 195.88 | 69.18 |
| PB | 1.84 | 64/280 | 1.90 | 1.78 | 1.39 |
| PS (TTM) | 3.35 | 156/280 | 3.42 | 3.19 | 2.41 |
| Dividend Yield | 0.45% | 148/280 | 0.77% | 0.46% | 0.43% |

## Institutional View

### Analyst Rating Distribution

> As of 2024-09-20T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 1 | 100% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 13.36 |

## References

- [Company Overview](https://longbridge.com/en/quote/688203.SH/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/688203.SH/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/688203.SH/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.